Machine Learning Intervention Triples Serious Illness Conversations Among Oncology Clinicians
October 22, 2020

An intervention that delivered machine learning mortality predictions with behavioral nudges to oncology clinicians significantly increased the rate of serious illness conversations among all patients included in this study.

SGX301 Demonstrates Positive Benefits for Cutaneous T-Cell Lymphoma
October 22, 2020

Cycle 3 of the FLASH study reported that patients taking SGX301 to treat cutaneous t-cell lymphoma saw improved responses and maintained a positive safety profile.

Study Finds Radiation Remodels T-Cell Responses in Patients with RCC
October 22, 2020

Researchers demonstrated for the first time that radiation remodels T-cell responses found within the tumors of patients with renal cell carcinoma.

Study Analyzing Daratumumab to Treat Patients with Multiple Myeloma Induces Positive Topline Results
October 22, 2020

Genmab recently announced positive topline results from part 2 of the Phase 3 CASSIOPEIA study examining daratumumab monotherapy as maintenance therapy to treat patients diagnosed with multiple myeloma.

Combined Study Analysis Determines Best Drug Choices for Patients with Advanced Breast Cancer
October 21, 2020

Detection of ESR1 mutations in baseline ctDNA was associated with inferior progression-free survival and overall survival in patients with advanced HR-positive breast cancer treated with exemestane versus fulvestrant.

NCI-MATCH Supports Using NGS to Triage Patients to Investigational Therapy
October 21, 2020

Results from NCI-MATCH support the feasibility and efficiency of using next-generation sequencing (NGS) to triage patients to investigational therapy, provided that a sufficiently large pool of agents is made available.